Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Plasmodium asexual blood stages encompass the developmental forms of the malaria parasite that replicate within human red blood cells (erythrocytes), and are responsible for symptomatic malaria. These stages include the ring, trophozoite, and schizont phases. The parasite invades red cells, digests hemoglobin, remodels the host cell (including its cytoskeleton and membrane), and ultimately produces segmented schizonts that release daughter merozoites, which can reinvade new red blood cells. All clinical manifestations of malaria are linked to the asexual blood stages, which are the target of most drugs and are central to malaria pathology and transmission
Inhibition of heme detoxification (e.g., chloroquine) Generation of reactive oxygen species (e.g., artemisinin) Inhibition of folate synthesis (e.g., pyrimethamine, sulfadoxine) Disruption of electron transport (e.g., atovaquone) Inhibition of protein synthesis (various mechanisms)
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Plasmodium asexual blood stage.